SynthesisMedicine2022

The association of efficacy with PD-1/PD-L1 inhibition and tumor mutational burden in advanced nonsmall cell lung cancer: A PRISMA-guided literature review and meta-analysis.

Dahui Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.